• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光动力疗法治疗真菌性角膜炎的最新进展

Recent Advances in Photodynamic Therapy against Fungal Keratitis.

作者信息

Hung Jia-Horung, Lee Chaw-Ning, Hsu Huai-Wen, Ng I-Son, Wu Chi-Jung, Yu Chun-Keung, Lee Nan-Yao, Chang Yun, Wong Tak-Wah

机构信息

Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan.

Department of Ophthalmology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.

出版信息

Pharmaceutics. 2021 Nov 26;13(12):2011. doi: 10.3390/pharmaceutics13122011.

DOI:10.3390/pharmaceutics13122011
PMID:34959293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8709008/
Abstract

Fungal keratitis is a serious clinical infection on the cornea caused by fungi and is one of the leading causes of blindness in Asian countries. The treatment options are currently limited to a few antifungal agents. With the increasing incidence of drug-resistant infections, many patients fail to respond to antibiotics. Riboflavin-mediated corneal crosslinking (similar to photodynamic therapy (PDT)) for corneal ectasia was approved in the US in the early 2000s. Current evidence suggests that PDT could have the potential to inhibit fungal biofilm formation and overcome drug resistance by using riboflavin and rose bengal as photosensitizers. However, only a few clinical trials have been initiated in anti-fungal keratitis PDT treatment. Moreover, the removal of the corneal epithelium and repeated application of riboflavin and rose bengal are required to improve drug penetration before and during PDT. Thus, an improvement in trans-corneal drug delivery is mandatory for a successful and efficient treatment. In this article, we review the studies published to date using PDT against fungal keratitis and aim to enhance the understanding and awareness of this research area. The potential of modifying photosensitizers using nanotechnology to improve the efficacy of PDT on fungal keratitis is also briefly reviewed.

摘要

真菌性角膜炎是由真菌引起的角膜严重临床感染,是亚洲国家失明的主要原因之一。目前的治疗选择仅限于少数抗真菌药物。随着耐药性感染的发病率不断上升,许多患者对抗生素没有反应。21世纪初,核黄素介导的角膜交联(类似于光动力疗法(PDT))用于治疗角膜扩张在美国获得批准。目前的证据表明,通过使用核黄素和孟加拉玫瑰红作为光敏剂,光动力疗法可能具有抑制真菌生物膜形成和克服耐药性的潜力。然而,只有少数临床试验已在抗真菌性角膜炎光动力疗法治疗中开展。此外,在光动力疗法之前和期间,需要去除角膜上皮并反复应用核黄素和孟加拉玫瑰红以提高药物渗透性。因此,改善角膜药物递送对于成功和有效的治疗是必不可少的。在本文中,我们回顾了迄今为止发表的使用光动力疗法治疗真菌性角膜炎的研究,旨在增进对该研究领域的理解和认识。还简要回顾了使用纳米技术修饰光敏剂以提高光动力疗法治疗真菌性角膜炎疗效的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70e5/8709008/1dd88fc6dbbb/pharmaceutics-13-02011-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70e5/8709008/ca6205b24ecc/pharmaceutics-13-02011-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70e5/8709008/5ea9c11663ad/pharmaceutics-13-02011-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70e5/8709008/227bdb56ec49/pharmaceutics-13-02011-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70e5/8709008/6cdcf875026d/pharmaceutics-13-02011-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70e5/8709008/1dd88fc6dbbb/pharmaceutics-13-02011-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70e5/8709008/ca6205b24ecc/pharmaceutics-13-02011-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70e5/8709008/5ea9c11663ad/pharmaceutics-13-02011-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70e5/8709008/227bdb56ec49/pharmaceutics-13-02011-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70e5/8709008/6cdcf875026d/pharmaceutics-13-02011-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70e5/8709008/1dd88fc6dbbb/pharmaceutics-13-02011-g005.jpg

相似文献

1
Recent Advances in Photodynamic Therapy against Fungal Keratitis.光动力疗法治疗真菌性角膜炎的最新进展
Pharmaceutics. 2021 Nov 26;13(12):2011. doi: 10.3390/pharmaceutics13122011.
2
Assessment of rose bengal versus riboflavin photodynamic therapy for inhibition of fungal keratitis isolates.评估玫瑰红 Bengal 与核黄素光动力疗法对真菌性角膜炎分离株的抑制作用。
Am J Ophthalmol. 2014 Jul;158(1):64-70.e2. doi: 10.1016/j.ajo.2014.04.007. Epub 2014 Apr 29.
3
Novel Photodynamic/Photothermal Treatment of Fungal Keratitis Using Rose Bengal-Loaded Polypyrrole-Gold Nanoparticles in Wistar Albino Rats.载玫瑰红 Bengal 的聚吡咯-金纳米粒子用于 Wistar 白化大鼠真菌性角膜炎的新型光动力/光热治疗。
J Ocul Pharmacol Ther. 2023 Jul;39(6):379-388. doi: 10.1089/jop.2023.0004. Epub 2023 Jun 30.
4
A double-masked, sham-controlled trial of rose bengal photodynamic therapy for the treatment of fungal and acanthamoeba keratitis: Rose Bengal Electromagnetic Activation with Green Light for Infection Reduction (REAGIR) study.双盲、假对照的玫瑰红 Bengal 光动力疗法治疗真菌和棘阿米巴角膜炎的临床试验:减少感染的孟加拉玫瑰电磁激活绿光(REAGIR)研究。
Trials. 2024 Aug 28;25(1):566. doi: 10.1186/s13063-024-08376-3.
5
[Photodynamic therapy for infectious keratitis].[光动力疗法治疗感染性角膜炎]
Ophthalmologe. 2012 Feb;109(2):165-70. doi: 10.1007/s00347-011-2511-x.
6
A double-masked, sham-controlled trial of rose bengal photodynamic therapy for the treatment of fungal and acanthameoba keratitis: Rose Bengal Electromagnetic Activation with Green Light for Infection Reduction (REAGIR) Study.孟加拉玫瑰红光动力疗法治疗真菌和棘阿米巴角膜炎的双盲、假对照试验:孟加拉玫瑰红绿光电磁激活减少感染(REAGIR)研究
Res Sq. 2024 Jul 2:rs.3.rs-4165312. doi: 10.21203/rs.3.rs-4165312/v1.
7
Mitochondria-Specific Aggregation-Induced Emission Luminogens for Selective Photodynamic Killing of Fungi and Efficacious Treatment of Keratitis.用于选择性光动力杀伤真菌和有效治疗角膜炎的线粒体特异性聚集诱导发射发光体。
ACS Nano. 2021 Jul 27;15(7):12129-12139. doi: 10.1021/acsnano.1c03508. Epub 2021 Jun 28.
8
Fungal Keratitis: Diagnosis, Management, and Recent Advances.真菌性角膜炎:诊断、治疗及最新进展
Clin Ophthalmol. 2024 Jan 10;18:85-106. doi: 10.2147/OPTH.S447138. eCollection 2024.
9
Epidemiological profile of fungal keratitis in urban population of West Bengal, India.印度西孟加拉邦城市人口中真菌性角膜炎的流行病学概况。
Oman J Ophthalmol. 2009 Sep;2(3):114-8. doi: 10.4103/0974-620X.57310.
10
Antimicrobial efficacy of corneal cross-linking in vitro and in vivo for Fusarium solani: a potential new treatment for fungal keratitis.体外及体内角膜交联对茄病镰刀菌的抗菌疗效:真菌性角膜炎的一种潜在新疗法
BMC Ophthalmol. 2018 Mar 2;18(1):65. doi: 10.1186/s12886-018-0727-0.

引用本文的文献

1
Exploring the potential of photodynamic therapy in overcoming multidrug resistance: mechanisms, synergies, and clinical advancements in infectious diseases.探索光动力疗法在克服多重耐药性方面的潜力:机制、协同作用及传染病领域的临床进展
Front Cell Infect Microbiol. 2025 Aug 14;15:1624036. doi: 10.3389/fcimb.2025.1624036. eCollection 2025.
2
Nanomedicine in fungal keratitis: current applications and future prospects.纳米医学在真菌性角膜炎中的应用现状与未来展望
Front Microbiol. 2025 Jul 9;16:1618046. doi: 10.3389/fmicb.2025.1618046. eCollection 2025.
3
Photodynamic therapy could serve as a promising approach to prevent posterior capsular opacification.

本文引用的文献

1
Photodynamic Therapy for Infectious Keratitis.感染性角膜炎的光动力疗法
Curr Ophthalmol Rep. 2020 Dec;8:245-251. doi: 10.1007/s40135-020-00252-y. Epub 2020 Sep 12.
2
Spatial Distribution of a Porphyrin-Based Photosensitizer Reveals Mechanism of Photodynamic Inactivation of .一种基于卟啉的光敏剂的空间分布揭示了……的光动力失活机制 。 (你提供的原文似乎不完整,最后的“of”后面缺少具体内容。)
Front Med (Lausanne). 2021 Jul 19;8:641244. doi: 10.3389/fmed.2021.641244. eCollection 2021.
3
Antimicrobial nanomedicine for ocular bacterial and fungal infection.
光动力疗法可能是预防后囊膜混浊的一种有前景的方法。
Photochem Photobiol Sci. 2025 May;24(5):681-691. doi: 10.1007/s43630-025-00707-w. Epub 2025 May 7.
4
Toxicological Assessment of 2-Hydroxychalcone-Mediated Photodynamic Therapy: Comparative In Vitro and In Vivo Approaches.2-羟基查尔酮介导的光动力疗法的毒理学评估:体外和体内比较研究方法
Pharmaceutics. 2024 Nov 26;16(12):1523. doi: 10.3390/pharmaceutics16121523.
5
Photodynamic antimicrobial therapy with Erythrosin B, Eosin Y, and Rose Bengal for the inhibition of fungal keratitis isolates: An in vitro study.用赤藓红B、伊红Y和孟加拉玫瑰红进行光动力抗菌疗法对真菌性角膜炎分离株的抑制作用:一项体外研究。
J Photochem Photobiol B. 2025 Feb;263:113090. doi: 10.1016/j.jphotobiol.2024.113090. Epub 2024 Dec 27.
6
Antifungal efficacy of photodynamic therapy on Cryptococcus and Candida species is enhanced by Streptomyces spp. extracts in vitro.在体外,链霉菌属提取物增强了光动力疗法对隐球菌和念珠菌属真菌的抗真菌疗效。
Lasers Med Sci. 2024 Oct 10;39(1):255. doi: 10.1007/s10103-024-04204-x.
7
Applications of photodynamic therapy in keratitis.光动力疗法在角膜炎中的应用。
Int Ophthalmol. 2024 Mar 15;44(1):140. doi: 10.1007/s10792-024-03062-4.
8
An Overview of Biofilm-Associated Infections and the Role of Phytochemicals and Nanomaterials in Their Control and Prevention.生物膜相关感染概述以及植物化学物质和纳米材料在其控制与预防中的作用
Pharmaceutics. 2024 Jan 24;16(2):162. doi: 10.3390/pharmaceutics16020162.
9
Recent Advances in Diagnosis and Treatment Approaches in Fungal Keratitis: A Narrative Review.真菌性角膜炎诊断与治疗方法的最新进展:一项叙述性综述
Microorganisms. 2024 Jan 13;12(1):161. doi: 10.3390/microorganisms12010161.
10
Scleral collagen cross linkage in progressive myopia.进行性近视中的巩膜胶原交联
Indian J Ophthalmol. 2024 Feb 1;72(2):174-180. doi: 10.4103/IJO.IJO_1392_23. Epub 2023 Dec 26.
用于眼部细菌和真菌感染的抗菌纳米医学。
Drug Deliv Transl Res. 2021 Aug;11(4):1352-1375. doi: 10.1007/s13346-021-00966-x. Epub 2021 Apr 11.
4
Efficacy of Toluidine Blue-Mediated Antimicrobial Photodynamic Therapy on spp. A Systematic Review.甲苯胺蓝介导的抗菌光动力疗法对[具体菌种]的疗效:一项系统评价
Antibiotics (Basel). 2021 Mar 25;10(4):349. doi: 10.3390/antibiotics10040349.
5
The global incidence and diagnosis of fungal keratitis.真菌性角膜炎的全球发病与诊断。
Lancet Infect Dis. 2021 Mar;21(3):e49-e57. doi: 10.1016/S1473-3099(20)30448-5. Epub 2020 Oct 22.
6
Detection of singlet oxygen luminescence for experimental corneal rose bengal photodynamic antimicrobial therapy.用于实验性角膜孟加拉玫瑰红光动力抗菌治疗的单线态氧发光检测。
Biomed Opt Express. 2020 Dec 10;12(1):272-287. doi: 10.1364/BOE.405601. eCollection 2021 Jan 1.
7
Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance.感染性角膜炎:流行病学、致病微生物、危险因素及抗菌药物耐药性的最新进展
Eye (Lond). 2021 Apr;35(4):1084-1101. doi: 10.1038/s41433-020-01339-3. Epub 2021 Jan 7.
8
Safety and efficacy of repeated crosslinking assisted by transepithelial double-cycle iontophoresis in keratoconus progression after primary corneal crosslinking.经上皮双循环离子导入辅助重复交联在原发性角膜交联术后圆锥角膜进展中的安全性和有效性。
Eye (Lond). 2021 Nov;35(11):3020-3027. doi: 10.1038/s41433-020-01365-1. Epub 2021 Jan 7.
9
Ectatic diseases.扩张性疾病。
Exp Eye Res. 2021 Jan;202:108347. doi: 10.1016/j.exer.2020.108347. Epub 2020 Dec 1.
10
The Incidence and Outcomes of Recurrence of Infection after Therapeutic Penetrating Keratoplasty for Medically-Uncontrolled Infectious Keratitis.药物治疗无法控制的感染性角膜炎行穿透性角膜移植术后感染复发的发生率及转归
J Clin Med. 2020 Nov 18;9(11):3696. doi: 10.3390/jcm9113696.